- Home
- WEA vs THTX Comparison
WEA vs THTX Comparison
Compare WEA & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEA
- THTX
- Stock Information
- Founded
- WEA 2002
- THTX 1993
- Country
- WEA United States
- THTX Canada
- Employees
- WEA N/A
- THTX N/A
- Industry
- WEA Trusts Except Educational Religious and Charitable
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- WEA Finance
- THTX Health Care
- Exchange
- WEA Nasdaq
- THTX Nasdaq
- Market Cap
- WEA 129.6M
- THTX 144.8M
- IPO Year
- WEA N/A
- THTX N/A
- Fundamental
- Price
- WEA $10.91
- THTX $3.24
- Analyst Decision
- WEA
- THTX Hold
- Analyst Count
- WEA 0
- THTX 1
- Target Price
- WEA N/A
- THTX N/A
- AVG Volume (30 Days)
- WEA 46.1K
- THTX 249.2K
- Earning Date
- WEA 01-01-0001
- THTX 10-09-2025
- Dividend Yield
- WEA 7.87%
- THTX N/A
- EPS Growth
- WEA N/A
- THTX N/A
- EPS
- WEA N/A
- THTX N/A
- Revenue
- WEA N/A
- THTX $84,378,000.00
- Revenue This Year
- WEA N/A
- THTX N/A
- Revenue Next Year
- WEA N/A
- THTX $13.76
- P/E Ratio
- WEA N/A
- THTX N/A
- Revenue Growth
- WEA N/A
- THTX 2.19
- 52 Week Low
- WEA $9.60
- THTX $1.12
- 52 Week High
- WEA $11.29
- THTX $3.25
- Technical
- Relative Strength Index (RSI)
- WEA 56.73
- THTX 74.26
- Support Level
- WEA $10.82
- THTX $3.18
- Resistance Level
- WEA $10.95
- THTX $3.22
- Average True Range (ATR)
- WEA 0.07
- THTX 0.02
- MACD
- WEA 0.01
- THTX -0.01
- Stochastic Oscillator
- WEA 78.95
- THTX 90.00
About WEA Western Asset Bond Fund Share of Beneficial Interest
Western Asset Premier Bond Fund is a diversified closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The Fund invests in sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.